BIOMAT Database Logo BIOMAT Database Logo

[Clinical experiences with a new muscle relaxant (DS 103-282 Sandoz) (author's transl)]. 1977

E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D009128 Muscle Spasticity A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54) Clasp-Knife Spasticity,Spastic,Clasp Knife Spasticity,Spasticity, Clasp-Knife,Spasticity, Muscle
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[Long-term treatment with an imidazoline derivative (DS 103--282) (author's transl)].
December 1979, Der Nervenarzt,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
A new skeletal muscle relaxant (DS 103-282) compared to diazepam in the treatment of muscle spasm of local origin.
January 1981, The Journal of international medical research,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[The effect of DS 103--282, a new type of myotonolyticum, on the contractile mechanism in human skeletal muscle (author's transl)].
July 1977, Der Nervenarzt,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[Clinical experiences with a new muscle relaxant ah 8165--a derivate from azobis-arylimidazo-pyridinium (author's transl)].
October 1974, MMW, Munchener medizinische Wochenschrift,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
January 1981, Current medical research and opinion,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
Selective antinociceptive effects of tizanidine (DS 103-282), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord.
June 1984, British journal of pharmacology,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[Clinical experiences with a new muscle relaxant in obstetrics].
September 1955, Deutsches medizinisches Journal,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[Experiences with a new muscle relaxant Pavulon].
July 1970, Der Anaesthesist,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[Clinical experiences with the new muscle relaxant GGG forte].
August 1957, Das Deutsche Gesundheitswesen,
E Ringwald, and S J Campean, and F Gerstenbrand, and A Lorincz, and P Lörincz, and H P Ludin
[Pancuronium bromide. Clinical experiences with a new steroid-like muscle relaxant].
May 1970, Der Anaesthesist,
Copied contents to your clipboard!